ReadYourDNA

rs10790162 (BUD13)

What you carry at this position in your DNA and what research says about it.

Triglyceride Levels: 10/10 evidence, 8 publications.

You're viewing every possible genotype for this variant.

None of these is your result. Use the genotype toggle to compare them, then sign up and upload your DNA to see which one is yours.

Sample genotype (not yours): A/A

Elevated Triglycerides and Metabolic Risk

Two copies of the minor A allele are linked to significantly higher blood triglyceride levels and an increased risk of metabolic syndrome.

What this genotype means: Significantly higher blood triglyceride levels; Increased risk of metabolic syndrome; Elevated risk of coronary artery disease.

Sample genotype (not yours): A/G

Moderately Higher Triglycerides and Metabolic Risk

One copy of the minor A allele is associated with moderately elevated triglyceride levels and a slightly higher risk of metabolic syndrome.

What this genotype means: Moderately higher blood triglyceride levels; Slightly increased risk of metabolic syndrome; Modestly elevated cardiovascular risk.

Sample genotype (not yours): G/G

Typical Triglycerides and Lower Metabolic Risk

Two copies of the major G allele are associated with typical blood triglyceride levels and a lower risk of metabolic syndrome.

What this genotype means: Typical blood triglyceride levels; Lower risk of metabolic syndrome; Standard baseline cardiovascular risk.

About BUD13

Gene function and biological role

Gene Function: BUD13 homolog encodes a protein that functions as a subunit of the retention and splicing complex, which is essential for proper pre-mRNA splicing [1]. Located on chromosome 11, this gene resides within a well-characterized gene cluster that heavily influences lipid metabolism and cardiovascular risk [1]. Splicing regulators like BUD13 are crucial for the post-transcriptional control of metabolic pathways in the liver and adipose tissue [2]. Variations in this gene can alter the expression of nearby lipid-regulating genes, directly impacting how the body processes fats [2].

Variant Impact: The rs10790162 variant is an intronic change located within the BUD13 gene that influences circulating blood lipid levels [1]. This genetic variation alters the splicing efficiency or expression of lipid-clearing proteins, leading to differences in fat accumulation in the bloodstream [1]. Studies across diverse populations have linked this specific genetic marker to variations in triglycerides, cholesterol fractions, and overall metabolic health [3]. Because it sits in a highly active metabolic gene region, its downstream effects extend to cardiovascular risk profiles [3].

Key Insight: This variant is part of a tightly linked cluster of genes on chromosome 11 that acts as a major control hub for blood lipid levels across global populations.

Location: BUD13. Chromosome 11 · 11q23.3 · 116.8 Mb

Genotype Frequencies

Estimated prevalence by population

Global 0.7%; European 0.5%; African < 0.1%; East Asian 5.2%; South Asian 3.6%; Americas 1.3%; Ashkenazi 0.8%; Finnish 0.7%; Middle Eastern 1.1%; Amish 1.1%.

Estimated AA genotype frequency.

Global 12.7%; European 13.2%; African 3.1%; East Asian 35.2%; South Asian 30.9%; Americas 20.2%; Ashkenazi 16.4%; Finnish 15.0%; Middle Eastern 18.9%; Amish 18.5%.

Estimated AG genotype frequency.

Global 86.5%; European 86.3%; African 96.9%; East Asian 59.6%; South Asian 65.5%; Americas 78.5%; Ashkenazi 82.8%; Finnish 84.3%; Middle Eastern 80.0%; Amish 80.4%.

Estimated GG genotype frequency.

Associated Traits

Showing effects for A/A genotype

Cardiovascular & Metabolic

Lipids & Cholesterol

Triglycerides. Evidence: 10/10. Source: PMID 21386085. Significantly Higher.

Total Cholesterol. Evidence: 9/10. Source: PMID 35945198. Elevated.

Metabolic Syndrome & Insulin Resistance

Metabolic Syndrome. Evidence: 6/10. Source: PMID 21386085. Increased Risk.

Heart Disease

Coronary Artery Disease. Evidence: 5/10. Source: PMID 35915156. Increased Risk.

Showing effects for A/G genotype

Triglycerides. Evidence: 10/10. Source: PMID 21386085. Moderately Higher.

Total Cholesterol. Evidence: 9/10. Source: PMID 35945198. Slightly Elevated.

Metabolic Syndrome. Evidence: 6/10. Source: PMID 21386085. Slightly Increased.

Coronary Artery Disease. Evidence: 5/10. Source: PMID 35915156. Slightly Increased.

Showing effects for G/G genotype

Triglycerides. Evidence: 10/10. Source: PMID 21386085. Typical Levels.

Total Cholesterol. Evidence: 9/10. Source: PMID 35945198. Typical Levels.

Metabolic Syndrome. Evidence: 6/10. Source: PMID 21386085. Typical Risk.

Coronary Artery Disease. Evidence: 5/10. Source: PMID 35915156. Typical Risk.

What AA Genotype Means

What this genotype means for the people who carry it

Sample genotype: AA (Homozygous)

Carrying two copies of the A allele is strongly associated with elevated circulating triglycerides and total cholesterol [1]. This genetic profile can impair the body's natural ability to clear fats from the bloodstream efficiently, leading to lipid accumulation [1]. Large-scale genome-wide association studies have consistently demonstrated that this genotype increases susceptibility to metabolic syndrome, a cluster of conditions that raise the risk of heart disease and type 2 diabetes [2]. Furthermore, the elevated lipid levels associated with this genotype contribute to a higher overall risk of coronary artery disease [3]. Managing dietary fat intake and maintaining regular physical activity are particularly relevant for individuals with this genetic makeup to help support healthy blood lipid profiles.

Significantly higher blood triglyceride levels; Increased risk of metabolic syndrome; Elevated risk of coronary artery disease.

What AG Genotype Means

Sample genotype: AG (Heterozygous)

Carrying a single copy of the A allele is linked to moderate increases in circulating triglycerides and total cholesterol [1]. This intermediate genetic profile suggests a slightly reduced efficiency in clearing dietary fats from the bloodstream compared to the common genotype [1]. Multi-ethnic genetic studies indicate that carriers of this single risk allele have a modestly increased likelihood of developing metabolic syndrome [2]. While the risk is less pronounced than in those with two copies of the A allele, it still contributes to a slightly elevated cardiovascular risk profile over time [3]. Emphasizing a heart-healthy lifestyle, including a balanced diet rich in unsaturated fats and regular exercise, can help mitigate these genetically influenced lipid elevations.

Moderately higher blood triglyceride levels; Slightly increased risk of metabolic syndrome; Modestly elevated cardiovascular risk.

What GG Genotype Means

Sample genotype: GG (Homozygous)

Carrying two copies of the common G allele is associated with optimal baseline lipid clearance and typical blood triglyceride levels [1]. This genotype represents the most common genetic profile globally, helping to maintain standard lipid processing and cholesterol transport [1]. Large-scale genomic analyses show that individuals with this profile have a lower risk of developing metabolic syndrome compared to carriers of the A allele [2]. Additionally, this genetic makeup is associated with a typical, non-elevated risk of coronary artery disease [3]. While overall cardiovascular health is still heavily influenced by lifestyle factors, this genotype provides a favorable genetic baseline for lipid metabolism.

Typical blood triglyceride levels; Lower risk of metabolic syndrome; Standard baseline cardiovascular risk.

Related Variants

Variants with shared genetic architecture

rs28927680 · BUD13 Gene · Chr 11 · Triglyceride Levels

rs6589565 · BUD13 Gene · Chr 11 · Cholesterol and Metabolism

rs180326 · BUD13 Gene · Chr 11 · Metabolic Syndrome Risk

Sources

Association between the MLX interacting protein-like, BUD13 homolog and zinc finger protein 259 gene polymorphisms and serum lipid levels.

A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.

Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci.

Large-scale genome-wide association study of coronary artery disease in genetically diverse populations.

Back to Variant Explorer

Content updated August 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com